Famous Patents
In 1879, Auguste Bartholdi received design patent number 11,023 titled "Design for a Statue". It was for the Statue of Liberty.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8148521 | Arthropodicidal anthranilamides This invention provides compounds of Formula 1, their N-oxides and agriculturally suitable salts wherein R1, R2, R3, R4a, R4b and R | 04/03/2012 |
| 8129524 | Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same Methods for preparing cyclic carbamates and thiocarbamates containing cyanopyrrole moieties and of the formula are provided: Z are the same or different and are H, optionally substituted C1 to C6 alkyl... | 03/06/2012 |
| 8129523 | Coupling process for generating reactive boron-containing derivatives of N-substituted pyrrole-2-carbonitriles to produce biaryls A convenient preparation of boron-containing compounds, borate salts, pyrrolecarbonitrile boron-containing compounds, N-substituted-pyrrole-2-carbonitrile boron-containing compounds, and derivatives thereof is provided. The present invention also provides for the us... | 03/06/2012 |
| 8080655 | Methods of making efavirenz and intermediates thereof The present invention provides a process for the preparation of Efavirenz. A compound of Formula 1: may be prepared by a process comprising cyclizing, in the presence of a first base, a compound of Formula 5 with a haloform... | 12/20/2011 |
| 7968709 | Process for preparing polymorph form II of tanaproget Tanaproget polymorph Form II, processes for preparing tanaproget polymorph Form II, pharmaceutical compositions including tanaproget polymorph Form II, micronized tanaproget polymorph Form II, and processes for converting Form II to tanaproget Form I are provided. A... | 06/28/2011 |
| 7915406 | Process for preparing a benzoxazinone The invention relates to a method for preparing a benzoxazinone comprising reacting an isatoic anhydride with an acylating compound in the presence of an N-alkyl imidazole, to a method for preparing a photo-stabilised composition, comprising adding a benzoxazinone a... | 03/29/2011 |
| 7897761 | Heterocyclic compound A compound represented by the following Formula (1): wherein, Het1 represents a bivalent five- or six-membered aromatic heterocyclic residue and may further be substituted; Xa to Xd each ind... | 03/01/2011 |
| 7786297 | Purified form of tanaproget Micronized tanaproget, purified tanaproget Form I, and micronized, purified tanaproget Form I are provided. Also provided are compositions containing one or more of the prepared tanaproget forms, methods of using one or more of the prepared tanaproget forms, and kit... | 08/31/2010 |
| 7582755 | Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same Methods for preparing cyclic carbamates and thiocarbamates containing cyanopyrrole moieties and of the formula are provided. Z are the same or different and are H, optionally substituted C1 to C6 alkyl, ... | 09/01/2009 |
| 7488822 | Cyclocarbamate derivatives as progesterone receptor modulators This invention provides compounds of Formula (I): wherein R1 and R2 are independent substituents or are fused to form spirocyclic rings; R3, RC, and R4 are as defined h... | 02/10/2009 |
| 7442696 | Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses This invention relates to compounds that bind to mineralocorticoid receptors and/or modulate activity of mineralocorticoid receptors, and to methods for making and using such compounds. Some embodiments relate to compounds of Formula I: | 10/28/2008 |
| 7423146 | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones A process for making a compound of formula 1 or a salt thereof, wherein: R1 and R2 are each independently H, halogen, or C1-4-alkyl, or R1 and R2 together ... | 09/09/2008 |
| 7408060 | Nonsteroidal progesterone receptor modulators This invention relates to nonsteroidal progesterone receptor modulators of general formula I, a process for their production, the use of progesterone receptor modulators for the production of pharmaceutical agents as well a... | 08/05/2008 |
| 7375104 | Long acting beta-2-agonists and their use as medicaments A compound of formula 1′ wherein: V is —CH2—, —NH—, or —O—; Ra and Rb are each independently hydrogen, C1-4-alkyl, or halogen-C1-4 | 05/20/2008 |
| 7358246 | Thioamide derivatives as progesterone receptor modulators Thioamide compounds, and specifically, thioamide pyrrole compounds, and preparation thereof are provided. These thioamide compounds can be used as progesterone receptor modulators, in contraception, and in the treatment of progesterone-related maladies. ... | 04/15/2008 |
| 7339057 | Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and carboxylic acid in the presence of a sulfonyl chloride and pyridine A method for preparing a fused oxazinone is disclosed in which (1) a carboxylic acid is contacted with a sulfonyl chloride in the presence of an optionally substituted pyridine compound, the nominal mole ratio of sulfonyl chloride to carboxylic acid being from about... | 03/04/2008 |
| 7332105 | Synergistic UV absorber combination A stabilizer composition comprising (A) a compound of the formula (I) wherein R is (CH2—CH2—O—)n, —R2; —CH2—CH(OH)—CH2—O—R2; or —CH(R3)—CO—O—R4 | 02/19/2008 |
| 7314883 | Anti-migraine treatments The present invention relates to methods of treating neurogenic vasodilation, neurogenic inflammaton, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstru... | 01/01/2008 |
| 7314932 | Methods for minimizing thioamide impurities Methods for minimizing the formation of thioamide compounds using decoy agents during reactions, such as thionations of carbonyl compounds containing nitrite groups, are provided. ... | 01/01/2008 |
| 7312211 | Pryanone compounds useful as reversible inhibitors of cysteine proteases Disclosed are cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (Ia) and (Ib) where R2, R3, R4, R6, R8 and Y are defined herein. The compounds are useful for treating autoimmune and othe... | 12/25/2007 |
| 7276601 | Method and preparing fused oxazinones A method for preparing a fused oxazinone is disclosed in which a carboxylic acid is contacted with a sulfonyl chloride and an isatoic anhydride in the presence of a tertiary amine, the nominal mole ratio of said sulfonyl chloride to said carboxylic acid being from a... | 10/02/2007 |
| 7247625 | 6-amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators Compounds having the structure of formula I are provided. In formula I, R1 is H, OH, substituted or unsubstituted C1 to C3 alkyl, C1 to C3 perfluoroalkyl, or COR6; R6 is H, substituted or u... | 07/24/2007 |
| 7220862 | Calcitonin gene related peptide receptor antagonists The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying th... | 05/22/2007 |
| 7205296 | Substituted 2H-1,3-benzoxazin-4(3H)-ones Substituted benzoxazin-4(3H)-ones are provided which are useful for treating thrombosis and for reducing the likelihood and/or severity of a secondary ischemic event in a patient. ... | 04/17/2007 |
| 7205402 | Synthesis of a benzoxazinone The present invention provides novel methods for the synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (III) which is useful as a human immunodeficien... | 04/17/2007 |
| 7192471 | Aryl-ureido benzoxazinone compounds Fluorescent pigment compounds comprising aryl-ureido benzoxazinone compounds of the general formula (I): wherein R1 is an substituted or unsubstituted aryl group, R2 and R3 are ea... | 03/20/2007 |
| 7189713 | Piperidine derivatives The present invention relates to piperidine derivatives of formula (I): R represents halogen or C1-4 alkyl R1 represents C1-4 alkyl;... | 03/13/2007 |
| 7173128 | Ultraviolet light absorbers The present invention relates to novel ultraviolet light absorbers of the benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole classes. The invention also relates to polymer and photographic compositions stabilized against the deleterious ef... | 02/06/2007 |
| 7169776 | Method of preparing alkylated salicylamides via a dicarboxylate intermediate The present invention relates to a method of preparing an alkylated salicylamide from a protected and activated salicylamide via a dicarboxylated salicylamide intermediate. The present invention also relates to dicarboxylic salicylamide delivery agent compounds for ... | 01/30/2007 |
| 7166592 | Nonsteroidal antiinflammatory agents Compounds of Formula 1 are useful in the treatment of inflammation. ... | 01/23/2007 |
| 7160882 | Long acting β-2-agonists and their use as medicaments The present invention relates to compounds of formula 1 wherein the groups X, Ra, Rb, R1, R1′, R2, R2′, R2″, R2′″,... | 01/09/2007 |
| 7115736 | Process for preparing imidazopyran derivatives A novel process for preparing imidazopyran derivatives of the formula: wherein R1 is halogen atom, hydrogen atom, C1 to C3 alkyl group, aryl group, or ary... | 10/03/2006 |
| 7081457 | Cyclothiocarbamate derivatives as progesterone receptor modulators Methods of using compounds which are progesterone receptor agonists for contraception and the treatment of progesterone-related maladies alone or in combination with an estrogen receptor agonist or progesterone receptor antagonist are provided. These compounds have ... | 07/25/2006 |
| 7071177 | P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents This invention relates to anti-inflammatory and analgesic compounds, especially to certain p-(sulfonyl)phenyl amino derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds. ... | 07/04/2006 |
| 7056915 | Compounds useful as reversible inhibitors of cysteine proteases Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds | 06/06/2006 |
| 7056914 | Benzoxazinone-derived compounds, their preparation and use as medicaments The present invention relates to Benzoxazinone-derived compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals. ... | 06/06/2006 |
| 7041665 | Benzoxazinone derivatives, their preparation and use as medicaments The present invention relates to new compounds of general formula (I), as well as to their physiologically acceptable salts, the procedures for their preparation, the intermediate compounds for obtaining them, the application of the compounds of general formula (I) ... | 05/09/2006 |
| 6982261 | Cyanopyrroles This invention provides a progesterone receptor antagonist of formula 1 having the structure wherein T is O, S, or absent; R1, and R2 are each, independently, hydrogen, alkyl, substituted alkyl; or... | 01/03/2006 |
| 6967251 | Reagents for labeling biomolecules having aldehyde or ketone moieties Novel fluorescent derivitization reagents are described that are suitable for coupling to biomolecules that contain aldehyde or ketone functional groups. In one embodiment is provided reagents that have the following formula: | 11/22/2005 |
| 6956034 | Oxazin(ethyl)one compounds used as fungicides Oxazin(ethi)one compounds of the formula I: in which the variables Z, R1, R2, R3 and n are as defined in claim 1 and A is a 5- or 6-membered carbocycle or a 5- or 6-membered hete... | 10/18/2005 |
